Arkolith/Insider Trading/LENZ/Form 4

Versant Ventures VI GP, L.P.

10% OwnerLENZ Therapeutics, Inc. (LENZ) · full profile →Form 4 · filed Jun 20, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10.1M
Net Open-Market Flow
-$10.1M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 20, 2025Sell(S)101K$30.35$3.1M1.0M
Jun 20, 2025Sell(S)134K$30.25$4.1M2.0M
Jun 18, 2025Sell(S)100K$29.95$3.0M1.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-088604) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML